Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11951227
Nanofiber structures and methods of use thereof
granted -
US 11952376
Substituted amino acids as integrin inhibitors
granted -
US 11952600
PH20 polypeptide variants, formulations and uses thereof
granted -
US 11952366
Substituted 1,3,5-triazines as inhibitors for a rho family of GTP-ases
granted -
US 11951114
Use of thyroid beta-agonists
granted -
US 11951206
Cell housing device
granted -
US 11952362
Compositions and methods for treating epigenetic disease
granted -
US 11952374
Bicyclic compounds
granted -
US 11952370
Selective ligands for modulation of GIRK channels
granted -
US 11951121
Compositions and methods for treating Huntington's disease
granted -
US 11951100
Formulations of RBP4 inhibitors and methods of use
granted -
US 11952427
Anti-CD40 antibodies and uses thereof
granted -
US 11951124
Tellurium nanowires with anticancer properties synthesized by green chemistry
granted -
US 11951118
Preparation of preliposomal annamycin lyophilizate
granted -
US 11952408
HPV-specific binding molecules
granted -
US 11952429
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 11951152
Microparticle compositions for controlled delivery of telmisartan and actinomycin D
granted -
US 11951212
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
granted -
US 11952402
Fusion protein containing trail and IgG binding domain and the uses thereof
granted -
US 11951176
Stabilization of glucagon by trehalose glycopolymer nanogels
granted -
WO 2024068265
PARTICULES DE TYPE VIRUS PRÉSENTANT DES ANTIGÈNES DU SARS-COV-2 UTILISÉES EN TANT QUE VACCINS DE RAPPEL ET LEURS UTILISATIONS
granted -
US 11944683
Pharmaceutical compositions comprising meloxicam
granted -
US 11944687
Carbohydrate conjugate RNA agents and process for their preparation
granted -
US 11946065
Transgene cassettes, AAV vectors, and AAV viral vectors for expression of human codon-optimized CSTB
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.